A bone marrow transplant is a medical procedure that can be used to cure diseases once thought incurable-especially certain cancers of the blood. Since its first successful use in the late 1960s, thousands of people have undergone bone marrow transplantation. But as successful as this procedure can be, it has significant side effects and the recovery process can be difficult. This program takes an in-depth look at how the procedure works to treat diseases like leukemia, multiple myeloma, and non-Hodgkin's lymphoma. It explores the different types of bone marrow transplants and shows the role stem cells play. It also features interviews with patients who have had bone marrow transplants; they give advice to others who may be considering this potentially life-saving procedure.
Physical Activity in Cancer Prevention discusses the fact that increased physical activity is associated with reduced risk for several cancers, as well as the fact that evidence suggests that a sedentary lifestyle is associated with increased levels of biomarkers associated with increased cancer risk. The DVD reviews several mechanism studies that examined the biological effects of weight loss and exercise relevant to cancer. Collectively, these investigations found that a greater amount of exercise and weight loss were associated with a lower cancer risk and had a stronger effect on cancer biomarkers.
Among the topics covered:
Epidemiology: physical activity
Exercise effects on cancer biomarkers-randomized clinical trial evidence
Breast cancer is probably the disease many women fear the most. But in numerous cases, breast cancer is not the automatic death sentence some people perceive it to be. There are effective treatments that can stop the cancer from growing. But when a woman is diagnosed with triple negative breast cancer many of those treatments don't work, so researchers have to find other options. This program features women who were diagnosed with triple negative breast cancer, shows what treatments are working to stop the cancer, and tells how women can live healthy, productive lives after being diagnosed and treated for this form of breast cancer.
Research indicates that physical activity, weight control, and a healthy diet can prevent approximately one-third of the most common cancers that occur in the United States. Changing the American Plate to Lower Cancer Risk: What Do We Say? offers a practical, hands-on overview of the impact of lifestyle on cancer risk and what people can do to lower their risk. The DVD also reviews research-validated messages about reducing cancer risk that are appropriate for the general public, as well as for cancer survivors.
Among topics covered:
Be as lean as possible without becoming underweight
Physical activity & reduced risk
Recommendation: to promote a healthy weight
Dietary strategy: putting together the pieces
Limit red meats and avoid processed meat
If consumed at all, limit alcoholic drinks to two for men and one for women a day
Limit consumption of salty foods and foods processed with salt
The deep tan was accidentally popularized by Coco Chanel, yet even when Bob Marley died of melanoma decades later, the general public was still not fully aware of the dangers of UV radiation. This program examines not only the medical and scientific aspects of skin cancer, but its cultural, historical, and social facets as well. Using nationally known experts and dramatic personal testimony, it describes symptoms and risk factors-including indiscriminate use of tanning beds-mole assessment, and the pioneering medical trials for melanoma that may revolutionize cancer treatments.
Note: Only available in the US, Canada, Hong Kong, Singapore, Taiwan, South Korea, Malaysia, Japan and South Africa.
Stephen L. Huber, MS, RPh; Cynthia Radford; Steven M. Grunberg, MD
This program features leading healthcare professionals giving presentations on the latest advances in the management of the side effects of chemotherapy. Discussions will include information on pharmacoeconomics of antiemetic therapy in oncology and appropriate use of antiemetic therapy. Specific topics include: Enhancing the Value of Antiemetics in Oncology; Reimbursement Environment in Antiemetic Therapy; Challenges in Antiemetic Therapy.
I. Craig Henderson, MD; John Kennedy, MD, FRCPI; William Gradishar, MD; Claudine Isaacs, MD
Leading medical experts making presentations on advances in the management and treatment of breast cancer, including new agents and combination therapies, emphasizing the role of chemotherapy.
William U. Shipley, MD(Moderator); Derek Raghavan, MD, PhD; Harry W. Herr, MD; Mark S. Soloway, MD; M'Liss A. Hudson, MD; Niall M. Heney, MD; Paul F. Schellhammer, MD; Donald S. Kaufman, MD
Topics include superficial and invisible bladder cancer, diagnosis of patients presenting with either hematuria and dysuria, endoscopic and intravesical chemotherapeutic methods, systematic chemotherapy for advanced bladder cancer.
Laszlo Tabar, MD; Linda Warren, MD; Richard Bird, MD; Jeffery Weinreb, MD; Kevin Fox, MD; Barbara Fowble, MD; Michael Osborne, MD; John Hainsworth, MD
Topics included in this program are: The effectiveness of mammographic screening; the diagnostic workup: mammography, sonography, MRI; and therapeutic options: radiotherapy, chemotherapy, and surgury.
Leta Truett, RN, MN, CCRN; Deborah M. Thorpe, PhD, RN, CS; Mary Cunningham, RN, MS; Talulah Ruger, RN, BSN
This program features physicians and doctors discussing various appropriate nursing rules and interventions in pain management. The major areas of discussion are as follows: acute or post-operative pain management - current techniques and therapies, barriers to effective management; chronic non-malignant pain management or behavioral/cognitive pain management- classifications of chronic non-malignant pain characteristics, data collection, and treatment, cancer pain management - dosing regimens; nursing assessment for acute, chronic non-malignant or cancer pain - current therapies and techniques, point controlled analgesia (PCA), epidural analgesia.
Gabriel Hortobagyi, MD; Barbara L. Weber, MD; Charles L. Vogel, MD
Intro on the Management of Advanced Breast Cancer and the Use of Standard Chemotherapy; Current Hormonal Therapy and New Hormonal Agents in the Management of Breast Cancer; New Agents, including Taxol and Taxotere; Use of Navelbine and Clinical Trial Results.
Nicholas Petrelli, MD,FACS - Neal Meropol, MD - Tyvin Rich, MD - Alan Venook, MD
Topics include: surgical therapy of metastatic disease; new drugs in the treatment of metastatic disease; intrahepatic chemotherapy of colorectal liver metastasis; adjuvant combined modality therapy for colorectal cancer.
Richard Champlin, MD; Bruce D. Cheson, MD; Michael Bishop, MD; Frederick R. Appelbuam, MD; Frank J. Giles, MD; Charles A. Schiffer, MD
For physicians who have interest in or occasion to diagnose or treat cancer patients. Presentations will feature discussions about various leukemias and treatments of the disease.
Joseph Oesterling, MD; Arthur Porter, MD; Anthony Zeitman, MD; Jerry Ritchie, MD; David Paulson, MD; Michael K. Brawer, MD
Featured topics of this program include the use of PSA in diagnosis and staging of prostate cancer, transrectal ultrasound, improving the results of radical treatment for locally advanced prostate cancer, radical prostatectomy, maximum androgen deprivation therapy, and radionuclide therapy for metastatic prostate cancer.
Management of low grade lymphoma, status of interferon in Hon-Hodgkin's lymphoma, treatment of HIV/AIDS related lymphomas and treatment of low grade lymphoma.
Everett E. Vokes, MD; Vince Miller, MD; Gregory A. Masters, MD; Bruce Hillner, MD
Most recent data in standard therapy for Stage IV; Describe the role of concurrent and chemoradiation in Stage III and other treatment, including vinorelbine tartrate and platinol; Understand the pharmcoeconomic impact; Identify early clinical results of current investigation on drugs; Discuss neoadjuvant treatment.
Seth Lerner, MD; Ron Bukowski, MD; Chris Logothetis, MD; Richard Williams, MD; Michael Sorodsky, MD
This program deals with testes cancer; bladder cancer- BCG, alternatives to BCG therapy, and metastatic bladder cancer; and renal cell cancer - single agent therapies including IL-2 high dose and alpha interferon, combination therapy of IL-2 low dose and alpha interferon, and surgery to treat renal cell - does it improve survivability.
This video describes the incidence, known etiologies, and common clinical manifestations of cancer; diagnostic tests, clinical therapy and comprehensive care for children undergoing these procedures. It integrates information about oncologic emergencies into plans for monitoring all children with cancer. The lecture looks at the most common solid tumors and leukemia in children, describes their treatment, and plan comprehensive nursing care. Students learn to assess the impact of cancer survival on children and use this information to plan for ongoing physiologic and psychosocial care in the children's futures.
Harold Harvey, MD; Richard Santen, MD; Paul Goss, MD; Andrea Manni, MD
Topics covered in this program include: new aromatase inhibitors; risks and benefits of adjuvant tamoxifen; potential prevention of breast cancer by hormonal therapies; optimal duration therapy with tamoxifen; post-menopausal estrogen replacement therapy.
This program describes the pap smear, the possibility of a false negative, and the development of cancer without a premalignant phase. It also explains dysplasia and the current methods of treating it, discusses the various human papilloma viruses and their cancer link, explains the treatment for cervical cancer, and stresses the importance of regular gynecological exams.
Diet, Nutrition, And Cancer Prevention - This program is about how you can take steps to help protect yourself and your family from various types of cancer. Many studies of the habits of people all over the world suggests that you can reduce the risk of getting cancer by making healthy choices about the food you eat, the beverages you drink, and whether or not you smoke. About 1/3 of all cancer deaths may be related to what we eat. Making positive choices in your diet every day promotes good nutrition and good health and may reduce your risk of some types of cancer. This program is designed for healthy people and its' recommendations are consistent with seven simple guidelines developed to help people eat and maintain a healthy diet.
Topics included in this safety video are: seven simple guidelines for a healthy diet, eat a wide variety of foods each day, maintain desirable weight, avoid too much fat, eat foods with adequate starch and fiber, avoid too much sugar, avoid too much sodium, and if you drink alcoholic beverages do so in moderation.
Paul Shelhamer, MD; Charles Metzger, MD; Anthony Zeitman, MD; Mark Solloway, MD
A prestigious panel of physicians discussing the management of prostate cancer with specific topics including: anti-androgens and the treatment of metastatic prostate cancer; management of prostate disease in a single specialty managed care environment; neoadjuvant therapy and radiotherapy.
Celeste Lindley, PharmD; Steven M. Grundberg, MD; John D. Hainsworth, MD; Stephen L. Huber, MS, RPh
Learn about determining the emetogenic potential for chemotherapy agents; review new class system and algorithm for determining emetogenic potential of combo chemotherapy regimens. Discussions include the rationale for stratification of antiemetic dosage based on the emetogenicicity of the chemotherapy regimen; appreciating the cost and revenue comparisons for the 5HT3 antiemetics based on dosing considerations and identifing strategies for enhancing the antiemetics in a variety of practice settings.
Steven M. Grunberg, MD; John D. Hainsworth, MD; Paul J. Hesketh, MD; Jane Nolte, PharmD
Pharmacoeconomics of antiemetic therapy, oral antiemetics replacing IV antiemetics, appropriate use of antiemetic therapy, and the management of cisplatin-induced delayed emesis
Everett E. Vokes, MD; Philip C. Hoffman, MD; Vincent A. Miller, MD; Gregory Masters, MD; Roman Perez-Soler, MD
Familiarization with the most recent data in standard therapy for Stage IV; Discuss neoadjuvant treatment of NSCLC; Describe the role of concurrent and chemoradiation in Stage III; Identification of early clinical results of current investigation on drugs.
This video lecture attempts to define cancer, differentiates benign from malignant neoplasms and describes the theories of carcinogenesis (formation of cancer). It explains and discusses known carcinogens and identifies risk factors for cancer. The lecture compares the mechanisms and characteristics of normal cells with those of malignant cells and physical and psychological effects of cancer on a patient. Students learn laboratory and diagnostic tests common used for cancer, the role of chemotherapy in cancer treatment and classify chemotherapeutic agents. Furthermore, the video looks at the role of surgery, radiation therapy, and biotherapy in the treatment of cancer. Participants learn causes and discuss the nursing interventions for common oncologic emergencies and attempt to design an appropriate teaching plan for clients with cancer and their families regarding cancer diagnosis, treatment, and coping strategies.
Richard Payne, MD; Lillian M. Nail, PhD, RN, FAAN; Carol P. Curtis, RN, MSN, OCN; Faith Ottery, MD, PhD, FACN; Deborah M. Thorpe, PhD, RN, CS
Discuss pain initiative and its impact on our country; understand the challenges in managing cancer pain; describe principles of pain management; recognize fatigue as a side-effect of cancer treatment and understand nutritional oncology as an approach to cost/complication prevention.
This presentation defines cancer, explains basic diagnosis methods and various treatment options. Risk factors associated with the development of cancer are outlined along with healthy lifestyle components associated with lowering cancer risks.
Judd W. Moul, MD; Myra Glajchen, DSW; David G. McLeod, MD, JD; Nancy A. Dawson, MD
New paradigm of metastatic prostate cancer in the '90's; psychosocial aspects of metastatic prostate cancer and pain management; comparisons and contrasts of prostate cancer: patients vs. physicians; medicolegal aspects; medical oncology perspective of metastatic prostate cancer/pain control.
Nicholas J. Vogelzang, MD; Robert Kilbourn, MD, PhD; Robert C. Flanigan, MD; Gerald W. Chodak, MD, FACS; Howard A. Burris, III, MD
Discuss the role of single agent chemotherapy or second line hormonal therapy for managing hormone refractory prostate cancer; describe results of clinical trials using combinations chemotherapy for metastatic, hormone-refractory prostate cancer; review the role of taxanes in treating metastatic disease. Be familiar with the most recent data for treating prostate cancer.
This program informs your students of the latest research on how cancers form and how they can be treated, the role of genes and gene mutations, as well as lifestyle changes that can prevent over 30% of cancers. Scientists are making great strides in the study of cancers. Video's engaging animations clearly illustrate what we have learned about how normal cells turn into cancerous cells. Program details the role of genes and gene mutations while examining how environmental factors (such as smoking) can cause genes to mutate. Students also see the human face of cancer through profiles of a teen survivor of lymphoblastic leukemia and other cancer survivors. Your students will understand the importance of early cancer screening plus steps they can take to prevent or greatly improve the outcome of a diagnosis of cancer.
DVD (Closed Captioned, With Teacher's Resource Book) / (Grades 7 - College) / 20 minutes
Aman U. Buzdar, MD; I. Craig Henderson, MD; Howard Hochster, MD
Discuss the diagnosis and treatment of breast cancer; Presentations on 1st and 2nd line treatments will cover cytotoxic chemotherapy (CMF, CAF, and new cytotoxic agents); Diverse hormonal agents, neoadjuvant treatments, and combination therapies.